Items Tagged ‘cyclooxygenase-2 inhibitors’

March 23, 2015

Treatment Outcomes in Stage III Colon Cancer Appear Better in Aspirin, COX-2 Inhibitor Users


According to the results of a study recently reported in the Journal of the National Cancer Institute, patients with stage III colon cancer who take aspirin or other agents that inhibit cyclooxygenase-2 near the time of adjuvant chemotherapy appear to have a lower risk of cancer recurrence. It has long been suggested that aspirin and […]

View full entry

Tags: aspirin, celecoxib, Colon Cancer, colorectal cancer, COX-2, cyclooxygenase-2 inhibitors, News, Stage III colon cancer